Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

doi:10.1084/jem.183.3.769

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Huang, A. Y.
	Articles by Levitsky, H. I.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Huang, A. Y.
	Articles by Levitsky, H. I.

Social Bookmarking

	What's this?

ARTICLES

Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

AY Huang, AT Bruce, DM Pardoll and HI Levitsky
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

Tumors engineered to express the costimulatory molecule B7-1 can elicit CD8+ cytotoxic T lymphocyte (CTL)-dependent antitumor responses in immunocompetent mice. It has been postulated that this result reflects direct priming of CTL by the modified tumor in vivo. Previous studies of the immune response to a B7-1- murine colon carcinoma expressing influenza nucleoprotein (NP) as a model tumor antigen have demonstrated the crucial role of bone marrow-derived antigen-presenting cells (APCs) in the priming of NP-specific CTL in vivo. In this system, no evidence of direct CTL priming by tumor was detected. We have performed a similar analysis to determine if B7-1 transfectant of this tumor results in the direct priming of CTL, and to compare this response to that primed by host APCs. When H-2b-->H-2bxd bone marrow chimeras were immunized with a single injection of CT26/NP/B7-1 (H-2d), NP-specific CTL were detected that were restricted to the bone marrow haplotype (H- 2b), but not to the tumor haplotype. In contrast, CTL recognizing the NP antigenic epitope in the context of the tumor's major histocompatibility complex were detectable only after multiple immunizations. These results suggest that whereas B7-1+ tumor vaccines result in some degree of direct presentation to CD8+ T cells, the dominant mechanism of CTL priming is through the uptake and presentation of tumor antigens by bone marrow-deprived APCs. However, repeated immunization with B7-1+ tumor cells can efficiently expand the directly primed CD8+ CTL population.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Matte, C. C., Cormier, J., Anderson, B. E., Athanasiadis, I., Liu, J., Emerson, S. G., Pear, W., Shlomchik, W. D. (2004). Graft-versus-leukemia in a retrovirally induced murine CML model: mechanisms of T-cell killing. Blood 103: 4353-4361 [Abstract] [Full Text]
Mapara, M. Y., Sykes, M. (2004). Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance. JCO 22: 1136-1151 [Abstract] [Full Text]
Jain, A., Slansky, J. E., Matey, L. C., Allen, H. E., Pardoll, D. M., Schulick, R. D. (2003). Synergistic Effect of a Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Tumor Vaccine and Systemic Interleukin-2 in the Treatment of Murine Colorectal Cancer Hepatic Metastases. Ann. Surg. Oncol. 10: 810-820 [Abstract] [Full Text]
Butterfield, L. H., Ribas, A., Dissette, V. B., Amarnani, S. N., Vu, H. T., Oseguera, D., Wang, H.-J., Elashoff, R. M., McBride, W. H., Mukherji, B., Cochran, A. J., Glaspy, J. A., Economou, J. S. (2003). Determinant Spreading Associated with Clinical Response in Dendritic Cell-based Immunotherapy for Malignant Melanoma. Clin. Cancer Res. 9: 998-1008 [Abstract] [Full Text]
Xia, J., Tanaka, Y., Koido, S., Liu, C., Mukherjee, P., Gendler, S. J., Gong, J. (2003). Prevention of Spontaneous Breast Carcinoma by Prophylactic Vaccination with Dendritic/Tumor Fusion Cells. J. Immunol. 170: 1980-1986 [Abstract] [Full Text]
Kelly, J. M., Takeda, K., Darcy, P. K., Yagita, H., Smyth, M. J. (2002). A Role for IFN-{gamma} in Primary and Secondary Immunity Generated by NK Cell-Sensitive Tumor-Expressing CD80 In Vivo. J. Immunol. 168: 4472-4479 [Abstract] [Full Text]
LaBelle, J. L., Hanke, C. A., Blazar, B. R., Truitt, R. L. (2002). Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia. Blood 99: 2146-2153 [Abstract] [Full Text]
Bai, X.-F., Bender, J., Liu, J., Zhang, H., Wang, Y., Li, O., Du, P., Zheng, P., Liu, Y. (2001). Local Costimulation Reinvigorates Tumor-Specific Cytolytic T Lymphocytes for Experimental Therapy in Mice with Large Tumor Burdens. J. Immunol. 167: 3936-3943 [Abstract] [Full Text]
Bai, X.-F., Gao, J.-X., Liu, J., Wen, J., Zheng, P., Liu, Y. (2001). On the Site and Mode of Antigen Presentation for the Initiation of Clonal Expansion of CD8 T Cells Specific for a Natural Tumor Antigen. Cancer Res. 61: 6860-6867 [Abstract] [Full Text]
Markiewicz, M. A., Fallarino, F., Ashikari, A., Gajewski, T. F. (2001). Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A. Int Immunol 13: 625-632 [Abstract] [Full Text]
Dembic, Z., Rottingen, J.-A., Dellacasagrande, J., Schenck, K., Bogen, B. (2001). Phagocytic dendritic cells from myelomas activate tumor-specific T cells at a single cell level. Blood 97: 2808-2814 [Abstract] [Full Text]
Tamura, H., Dong, H., Zhu, G., Sica, G. L., Flies, D. B., Tamada, K., Chen, L. (2001). B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 97: 1809-1816 [Abstract] [Full Text]
Guilloux, Y., Bai, X.-f., Liu, X., Zheng, P., Liu, Y. (2001). Optimal Induction of Effector but not Memory Antitumor Cytotoxic T Lymphocytes Involves Direct Antigen Presentation by the Tumor Cells. Cancer Res. 61: 1107-1112 [Abstract] [Full Text]
Todo, T., Martuza, R. L., Dallman, M. J., Rabkin, S. D. (2001). In Situ Expression of Soluble B7-1 in the Context of Oncolytic Herpes Simplex Virus Induces Potent Antitumor Immunity. Cancer Res. 61: 153-161 [Abstract] [Full Text]
Qi, L., Rojas, J.-M., Ostrand-Rosenberg, S. (2000). Tumor Cells Present MHC Class II-Restricted Nuclear and Mitochondrial Antigens and Are the Predominant Antigen Presenting Cells In Vivo. J. Immunol. 165: 5451-5461 [Abstract] [Full Text]
Plautz, G. E., Mukai, S., Cohen, P. A., Shu, S. (2000). Cross-Presentation of Tumor Antigens to Effector T Cells Is Sufficient to Mediate Effective Immunotherapy of Established Intracranial Tumors. J. Immunol. 165: 3656-3662 [Abstract] [Full Text]
Davila, E., Celis, E. (2000). Repeated Administration of Cytosine-Phosphorothiolated Guanine-Containing Oligonucleotides Together with Peptide/Protein Immunization Results in Enhanced CTL Responses with Anti-Tumor Activity. J. Immunol. 165: 539-547 [Abstract] [Full Text]
Sojka, D. K., Donepudi, M., Bluestone, J. A., Mokyr, M. B. (2000). Melphalan and Other Anticancer Modalities Up-Regulate B7-1 Gene Expression in Tumor Cells. J. Immunol. 164: 6230-6236 [Abstract] [Full Text]
Willimsky, G., Blankenstein, T. (2000). Interleukin-7/B7.1-encoding Adenoviruses Induce Rejection of Transplanted but not Nontransplanted Tumors. Cancer Res. 60: 685-692 [Abstract] [Full Text]
Surman, D. R., Dudley, M. E., Overwijk, W. W., Restifo, N. P. (2000). Cutting Edge: CD4+ T Cell Control of CD8+ T Cell Reactivity to a Model Tumor Antigen. J. Immunol. 164: 562-565 [Abstract] [Full Text]
Gorin, N. C., Estey, E., Jones, R. J., Levitsky, H. I., Borrello, I., Slavin, S. (2000). New Developments in the Therapy of Acute Myelocytic Leukemia. ASH Education Book 2000: 69-89 [Abstract] [Full Text]
Wild, J., Grusby, M. J., Schirmbeck, R., Reimann, J. (1999). Priming MHC-I-Restricted Cytotoxic T Lymphocyte Responses to Exogenous Hepatitis B Surface Antigen Is CD4+ T Cell Dependent. J. Immunol. 163: 1880-1887 [Abstract] [Full Text]
Motte, R. N. L., Sharpe, A. H., Bluestone, J. A., Mokyr, M. B. (1999). Host B7-1 and B7-2 Costimulatory Molecules Contribute to the Eradication of B7-1-Transfected P815 Tumor Cells Via a CD8+ T Cell-Dependent Mechanism. J. Immunol. 162: 4817-4823 [Abstract] [Full Text]
Shrikant, P., Mescher, M. F. (1999). Control of Syngeneic Tumor Growth by Activation of CD8+ T Cells: Efficacy Is Limited by Migration Away from the Site and Induction of Nonresponsiveness. J. Immunol. 162: 2858-2866 [Abstract] [Full Text]
La Motte, R. N., Sharpe, A. H., Bluestone, J. A., Mokyr, M. B. (1998). Importance of B7-1-Expressing Host Antigen-Presenting Cells for the Eradication of B7-2 Transfected P815 Tumor Cells. J. Immunol. 161: 6552-6558 [Abstract] [Full Text]
Cohen, Adam. D., Boyer, J. D., Weiner, D. B. (1998). Modulating the immune response to genetic immunization. FASEB J. 12: 1611-1626 [Abstract] [Full Text]
Sigal, L. J., Reiser, H., Rock, K. L. (1998). The Role of B7-1 and B7-2 Costimulation for the Generation of CTL Responses In Vivo. J. Immunol. 161: 2740-2745 [Abstract] [Full Text]
Bour, H., Horvath, C., Lurquin, C., Cerottini, J.-C., MacDonald, H. R. (1998). Differential Requirement for CD4 Help in the Development of an Antigen-Specific CD8+ T Cell Response Depending on the Route of Immunization. J. Immunol. 160: 5522-5529 [Abstract] [Full Text]
Mokyr, M. B., Kalinichenko, T. V., Gorelik, L., Bluestone, J. A. (1998). Importance of the B7-2 Molecule for Low Dose Melphalan-Induced Acquisition of Tumor-Eradicating Immunity by Mice Bearing a Large MOPC-315 Tumor. J. Immunol. 160: 1866-1874 [Abstract] [Full Text]
Armstrong, T. D., Clements, V. K., Ostrand-Rosenberg, S. (1998). MHC Class II-Transfected Tumor Cells Directly Present Antigen to Tumor-Specific CD4+ T Lymphocytes1. J. Immunol. 160: 661-666 [Abstract] [Full Text]
Wolpert, E. Z., Petersson, M., Chambers, B. J., Sandberg, J. K., Kiessling, R., Ljunggren, H.-G., Karre, K. (1997). Generation of CD8+ T cells specific for transporter associated with antigen processing deficient�cells. Proc. Natl. Acad. Sci. USA 94: 11496-11501 [Abstract] [Full Text]
Speiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall-Faienza, K., Odermatt, B., Hanahan, D., Zinkernagel, R. M., Ohashi, P. S. (1997). Self Antigens Expressed by Solid Tumors Do Not Efficiently Stimulate Naive or Activated T Cells: Implications for Immunotherapy. J. Exp. Med. 186: 645-653 [Abstract] [Full Text]
Dunussi-Joannopoulos, K., Krenger, W., Weinstein, H. J., Ferrara, J. L.M., Croop, J. M. (1997). CD8+ T Cells Activated During the Course of Murine Acute Myelogenous Leukemia Elicit Therapeutic Responses to Late B7 Vaccines After Cytoreductive Treatment. Blood 89: 2915-2924 [Abstract] [Full Text]